Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Alternatives for randomization in lifestyle intervention studies in cancer patients were not better than conventional randomization.

Velthuis MJ, May AM, Monninkhof EM, van der Wall E, Peeters PH.

J Clin Epidemiol. 2012 Mar;65(3):288-92. doi: 10.1016/j.jclinepi.2011.03.015.

PMID:
21856119
2.

Using the Zelen design in randomized controlled trials: debates and controversies.

Homer CS.

J Adv Nurs. 2002 Apr;38(2):200-7. Review.

PMID:
11940133
3.

[Pre-randomisation in study designs: getting past the taboo].

Schellings R, Kessels AG, Sturmans F.

Ned Tijdschr Geneeskd. 2008 Sep 20;152(38):2053-6. Dutch.

PMID:
18837179
4.

Zelen randomization: attitudes of parents participating in a neonatal clinical trial.

Snowdon C, Elbourne D, Garcia J.

Control Clin Trials. 1999 Apr;20(2):149-71.

PMID:
10227415
5.

Lay public's understanding of equipoise and randomisation in randomised controlled trials.

Robinson EJ, Kerr CE, Stevens AJ, Lilford RJ, Braunholtz DA, Edwards SJ, Beck SR, Rowley MG.

Health Technol Assess. 2005 Mar;9(8):1-192, iii-iv.

6.

Must research participants understand randomization?

Wendler D.

Am J Bioeth. 2009 Feb;9(2):3-8. doi: 10.1080/15265160802654145.

PMID:
19180378
7.

De facto masking and other measures to prevent contamination.

Berger VW.

J Clin Epidemiol. 2012 Nov;65(11):1236; author reply 1236-7. doi: 10.1016/j.jclinepi.2012.04.016. No abstract available.

PMID:
23017642
8.

Qualitative research in evidence-based medicine: improving decision-making and participation in randomized controlled trials of cancer treatments.

Audrey S.

Palliat Med. 2011 Dec;25(8):758-65. doi: 10.1177/0269216311419548. Epub 2011 Aug 15.

PMID:
21844137
9.

Beyond randomized controlled trials in attempted suicide research.

Hatcher S, Sharon C, Coggan C.

Suicide Life Threat Behav. 2009 Aug;39(4):396-407. doi: 10.1521/suli.2009.39.4.396. Review.

PMID:
19792981
10.

Randomised consent designs in cancer clinical trials.

Altman DG, Whitehead J, Parmar MK, Stenning SP, Fayers PM, Machin D.

Eur J Cancer. 1995 Nov;31A(12):1934-44. Review.

PMID:
8562145
11.

Pseudo cluster randomization dealt with selection bias and contamination in clinical trials.

Teerenstra S, Melis RJ, Peer PG, Borm GF.

J Clin Epidemiol. 2006 Apr;59(4):381-6. Epub 2006 Feb 14. Review.

PMID:
16549260
12.
13.

Clinical cancer research--some aspects on doctors' attitudes to informing participants.

Lynöe N, Sandlund M, Jacobsson L.

Acta Oncol. 1996;35(6):749-54.

PMID:
8938225
14.

Improving informed consent in clinical trials: a duty to experiment.

Lavori PW, Sugarman J, Hays MT, Feussner JR.

Control Clin Trials. 1999 Apr;20(2):187-93.

PMID:
10227417
15.

Randomization and the transactional framework for informed consent.

Reynolds D, Fleming DA.

Am J Bioeth. 2009 Feb;9(2):16-7. doi: 10.1080/15265160802666297. No abstract available.

PMID:
19180385
16.

Advantages and drawbacks of the Zelen design for randomized clinical trials.

Horwitz RI, Feinstein AR.

J Clin Pharmacol New Drugs. 1980 Jul;20(7):425-7. No abstract available.

PMID:
11658484
17.
18.

Randomization can be risky.

Lott J.

Am J Bioeth. 2009 Feb;9(2):17-8. doi: 10.1080/15265160802668954. No abstract available.

PMID:
19180386
19.

Understanding randomization: helpful strategies.

Brody H, Childress AM.

Am J Bioeth. 2009 Feb;9(2):14-5. doi: 10.1080/15265160802663245. No abstract available.

PMID:
19180384
20.

Indifference of subjects: an alternative to equipoise in randomized clinical trials.

Veatch RM.

Soc Philos Policy. 2002 Summer;19(2):295-323. No abstract available.

PMID:
12678091

Supplemental Content

Support Center